Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Thermogenesis Holdings Inc (THMO)
Thermogenesis Holdings Inc (THMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,340
  • Shares Outstanding, K 3,136
  • Annual Sales, $ 10,480 K
  • Annual Income, $ -11,270 K
  • 60-Month Beta 2.25
  • Price/Sales 0.34
  • Price/Cash Flow N/A
  • Price/Book 1.03
Trade THMO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3606 +189.79%
on 01/25/24
1.2500 -16.40%
on 02/20/24
+0.6499 (+164.49%)
since 01/22/24
3-Month
0.3606 +189.79%
on 01/25/24
1.2500 -16.40%
on 02/20/24
+0.0850 (+8.85%)
since 11/22/23
52-Week
0.3606 +189.79%
on 01/25/24
6.6700 -84.33%
on 03/17/23
-2.1050 (-66.83%)
since 02/22/23

Most Recent Stories

More News
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy...

THMO : 1.0609 (-0.38%)
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy...

THMO : 1.0609 (-0.38%)
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy...

THMO : 1.0609 (-0.38%)
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy...

THMO : 1.0609 (-0.38%)
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy...

THMO : 1.0609 (-0.38%)
Werewolf Therapeutics, Inc. (HOWL) Reports Q1 Loss, Tops Revenue Estimates

Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 30.61% and 46.36%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

HOWL : 6.89 (+4.08%)
THMO : 1.0609 (-0.38%)
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Lags Revenue Estimates

MaxCyte, Inc. (MXCT) delivered earnings and revenue surprises of 0% and 1.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MXCT : 4.51 (+0.22%)
THMO : 1.0609 (-0.38%)
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy...

THMO : 1.0609 (-0.38%)
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates

IDEAYA Biosciences, Inc. (IDYA) delivered earnings and revenue surprises of 3.92% and 45.02%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

IDYA : 44.89 (+1.35%)
THMO : 1.0609 (-0.38%)
Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of -18.27% and 4.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RARE : 49.00 (+1.70%)
THMO : 1.0609 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 1.1747
2nd Resistance Point 1.1373
1st Resistance Point 1.1012
Last Price 1.0609
1st Support Level 1.0277
2nd Support Level 0.9903
3rd Support Level 0.9542

See More

52-Week High 6.6700
Fibonacci 61.8% 4.2598
Fibonacci 50% 3.5153
Fibonacci 38.2% 2.7708
Last Price 1.0609
52-Week Low 0.3606

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar